CD4 and neoplasm: Furthermore, analysis of cDC2-deficient mice showed that cDC2 derived from tumor tissues enhances the ability of cDC1 to induce tumor-specific CTLs through the activation of CD4+ T cells in TdLNs (4–6, 12).